Page 14 - MSC & Exosomes in autoimmune

HUCB-Derived MSCs in Canine Cerebral Ischemia 3567

trophic factors reduce ischemic damage in the rat middle cerebral artery Nomura T, Honmou O, Harada K, Houkin K, Hamada H, Kosis JD.
occlusion model. Mol Ther 11:96–104. 2005. I.V. infusion of brain-derived neurotrophic factor gene-modified
Li Y, Chopp M, Chen J, Wang L, Gautam SC, Xu YX, Zhang Z. 2000. human mesenchymal stem cells protects against injury in a cerebral
Intrastriatal transplantation of bone marrow nonhematopoietic cells ischemia model in adult rat. Neuroscience 136:161–169.
improves functional recovery after stroke in adult mice. J Cereb Blood Platt SR, Garosi L. 2003. Canine cerebovascular disease: do dogs have
Flow Metab 9:1311–1319. strokes? J Am Anim Hosp Assoc 39:337–342.
Li Y, Chen J, Chen XG, Wang L, Gautam SC, Xu YX, Katakowski M, Purdy PD, Devous MD, Batjer HH, White CL, Meyer Y, Samson DS.
Zhang LJ, Lu M, Janakiraman N, Chopp M. 2002. Human marrow 1989. Microfibrillar collagen model of canine cerebral infarction. Stroke
stromal cell therapy for stroke in rat. Neurology 59:514–523. 20:1361–1367.
Lin TN, He YY, Wu G, Khan M, Hsu CY. 1993. Effect of brain edema
Sanchez-Ramos J, Song S, Cardozo-Pelaez F, Hazzi C, Stedeford T,
on infarct volume in a focal cerebral ischemia model in rats. Stroke
Willing A, Freeman TB, Saporta S, Janssen W, Patel N, Cooper DR,
24:117–121.
Sanberg PR. 2000. Adult bone marrow stromal cells differentiate into
Liu H, Honmou O, Harada K, Nakamura K, Houkin K, Hamada H,
neural cells in vitro. Exp Neurol 164:247–256.
Kocsis JD. 2006. Neuroprotection by PIGF gene-modified human mes-
Saunders DE, Clifton AG, Brown MM. 1995. Measurement of infarct
enchymal stem cells after cerebral ischemia. Brain 129:2734–2745.
size using MRI predicts prognosis in middle cerebral artery infarction.
Merino JG, Latour LL, Todd JW, Luby M, Schellinger PD, Kang DW,
Stroke 26:2272–2276.
Warach S. 2007. Lesion volume change after treatment with tissue plas-
Sun Y, Jin K, Xie L, Childs J, Mao XO, Logvinova A. 2003. VEGF-
minogen activator can discriminate clinical responders from nonres-
induced neuroprotection, neurogenesis, and angiogenesis after focal cer-
ponders. Stroke 38:2919–2923.
ebral ischemia. J Clin Invest 111:1843–1851.
Meschia JF, Miller DA, Brott TG. 2002. Thrombolytic treatment of
Vendrame M, Cassady J, Newcomb J, Butler R, Pennypacker KR,
acute ischemic stroke. Mayo Clin Proc 77:542–551.
Zigova T, Sandberg CD, Sandberg PR, Willing AE. 2004. Infusion of
Neumann-Haefelin T, Kastrup A, de Crespigny A, Yenari MA, Ringer
human umbilical cord blood cells in a rat model of stroke dose-depend-
T, Sun GH, Moseley ME, Fisher M. 2000. Serial MRI after transient
ently rescues behavioral deficits and reduces infarct volume. Stroke
focal cerebral ischemia in rats: dynamics of tissue injury, blood–brain
35:2390–2395.
barrier damage, and edema formation. Editorial comment: dynamics of
tissue injury, blood–brain barrier damage, and edema formation. Stroke Willing AE, Lixian J, Miliken M, Poulos S, Zigova T, Song S, Hart C,
31:1965–1973. Sanchez-Ramos J, Sandberg PR. 2003. Intravenous vs. intrastriatal cord
Newman MB, Davis CD, Kuzmin-Nichols N, Sanberg PR. 2003. blood administration in a rodent model of stroke. J Neurosci Res
Human umbilical cord blood (HUCB) cells for central nervous system 73:296–307.
repair. Neurotox Res 5:355–368. Zivin JA. 2000. Cell transplant therapy for stroke. Neurology 55:46.

Journal of Neuroscience Research